The note is the current scenario (Base). Download PDF renders this page on the server, fonts and colours exact; Print uses the browser.
Model Note · IOL CHEM AND PHARMA LTD · 11 September 2026Page 1 of 2
Model Note
Prepared by the reader · not a MarketPing document
IOL CHEM AND PHARMA LTD
Discounted cash flow · base FY26

IOL CHEM AND PHARMA LTD

Value per share, this model42
CMP 2026-09-10195.00
Difference(78.5)%
Growth the CMP implies45.0%/yr

This note states the assumptions and the arithmetic of one model of IOL CHEM AND PHARMA LTD, built on its filed FY26 consolidated statements. The value is the outcome of the assumptions below and nothing else; it is not a fair value, a target or a recommendation.

Assumptions

InputThis modelFiled reference
Revenue growth, 5 years11.5% a yearFY26 11.5% · 5-yr CAGR %
EBITDA margin11.1%FY26 11.1% · 5-yr average 10.6%
Depreciation · capex, % of revenue3.5% · 7.5%, fading to 1.2× depreciationFY26 3.5% · 7.5%
Working capital, % of added revenue · tax21.2% · 25.3%77 working-capital days · effective 25.3%
Discount rate11.00%1-yr beta 1.09
After FY315% flat · mid-year discounting
Net debt · non-controlling interest · non-operating investments67 · ₹0 · ₹0 crFY26 net debt ₹67 cr
Shares29.36 crore29.36 crore today
Source: SEBI results XBRL as filed with BSE/NSE, exchange prices; the reader's assumptions.

Projected cash flow to the firm

₹ croreFY26FY27FY28FY29FY30FY31
Revenue2,3192,5862,8833,2153,5843,997
growth %11.511.511.511.511.511.5
EBITDA258287320357398444
Depreciation(80)(91)(101)(113)(125)(140)
NOPAT133147164183203227
less capex(173)(194)(192)(188)(180)(168)
less working-capital build(57)(63)(70)(78)(87)
Free cash flow to firm(13)93770112
Present value(13)8284970
Source: the model; base year as filed.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
Model Note · IOL CHEM AND PHARMA LTD · 11 September 2026Page 2 of 2

From enterprise to equity

PV of the 5 explicit years142
PV of the terminal value (89% of EV)1,158
Enterprise value1,300
less net debt(67)
less non-controlling interest0
add non-operating investments0
Equity value1,233
÷ 29.36 crore shares42
Source: the model.

Sensitivity, ₹ per share

WACC ↓ · terminal growth →4.0%4.5%5.0%5.5%6.0%
10.0%4448525865
10.5%4043475157
11.0%3639424650
11.5%3335384145
12.0%3032353740
Source: the model; n/a where terminal growth reaches the discount rate.

Statement

This note is the reader's own model over publicly filed information: SEBI results XBRL filed with BSE and NSE and exchange price data, assembled by MarketPing software; every assumption above is the reader's. It contains no research recommendation, no price target and no opinion by MarketPing on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Historical per-share figures are on the current share count. Where a figure is unavailable the table shows a dash rather than an estimate. Nothing here constitutes investment advice, an offer or a solicitation.

Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in